Frailty in primary care: a review of its conceptualization and implications for practice by Lacas, Alethea & Rockwood, Kenneth
REVIEW Open Access
Frailty in primary care: a review of its
conceptualization and implications for practice
Alethea Lacas
1 and Kenneth Rockwood
2*
Abstract
Frail, older patients pose a challenge to the primary
care physician who may often feel overwhelmed by
their complex presentation and tenuous health status.
At the same time, family physicians are ideally suited
to incorporate the concept of frailty into their
practice. They have the propensity and skill set that
lends itself to patient-centred care, taking into
account the individual subtleties of the patient’s
health within their social context. Tools to identify
frailty in the primary care setting are still in the
preliminary stages of development. Even so, some
practical measures can be taken to recognize frailty in
clinical practice and begin to address how its
recognition may impact clinical care. This review seeks
to address how frailty is recognised and managed,
especially in the realm of primary care.
Keywords: frailty, primary care, frailty index, compre-
hensive geriatric assessment
Background
Thousands of times each day, physicians around the
world encounter older adults with multiple, interacting,
medical and social problems. Often, both they and their
patients can feel overwhelmed, and in an effort to start
somewhere, many focus on the illness which seems
most important, or the one with which they feel the
most comfortable. Many times they continue despite
confusion and difficulties, but even the most determined
physicians can share with their less tenacious colleagues
a feeling of frustration with the incompleteness of what
they offer in the face of so many needs. In this brief
review, we propose to cast this problem as one of the
complexity of frailty.
Our goals in this review of how to recognize and
address frailty in primary care are to show how frailty
can be conceptualized in relation to complexity, and
how principles having to do with the management of
complex systems that are close to failure can be
employed in everyday office practice to achieve better
care for frail older adults. Specifically, we propose to
look at what defines the “at risk” state that is frailty. We
will then address how recognizing frailty helps us in
managing older people who are frail. We also aim to
call attention to the reality that defining the prospect of
successful treatment requires understanding patients’
problems and life goals. In this, family physicians have a
natural advantage, given their training and predisposi-
tion towards thinking about not just diseases, but the
patients in whom they occur. We hope to show how
much of the intuition associated with this predisposition
and training can be leveraged in understanding frailty
and its determinants.
Complexity is a term that often is used synonymously
with frailty, or in some settings, with the idea of physical
frailty only [1]. Complexity has also been used in a
restricted sense - and not without controversy [2] - to
measure degrees of interaction in a system [3], or to
describe non-linear increases in vulnerability in relation
to the number of physiological systems showing dysre-
gulation in an individual [4]. As detailed elsewhere, in
general, a system is distinguished from a collection of
elements in a set by virtue of the relationships between
the elements having properties that depend on each
other and change as a consequence of their interaction
[5]. For example, grains of sand in a thimble appear to
show no interaction compared with a similar volume of
computer chips, which would have less interaction than
a similar volume made up of living organisms, such as a
snail or even algae... This definition shows the depen-
dence of a system on the frame of reference. For exam-
ple, the temperature of grains of sand in a thimble
would depend on the interaction of the grains, their
heat transfer, proximity to the sides of the container in
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ment, and so on. For our purposes, the complexity of
frailty is meant to convey the idea that, compared with
single system disorders in otherwise well people, man-
agement of older adults with multi-system dysregulation
must employ principles of complex systems manage-
ment, such as recognition of interconnectedness and
feedback (not additivity), indirect and delayed effects
(making root cause analysis difficult), impossibility of
implementing interventions with only one effect, and
results that cannot be predicted from separate actions
[6]. In a theoretical context, aging itself is a manifesta-
tion of complexity, being a multiply-determined phe-
nomenon (although mathematical modelling can be
employed to quantitate the extent of interactions in
aging, even at the cellular level [7]). Clinically, prescrib-
ing drugs is a common example, where drug choice and
dose adjustment depends not just on “renal dosing”,f o r
example, but on considering interactions, total number
of drugs already in place, ability of the patient to achieve
adherence, cost (including opportunity cost in relation
to time spent with dispensing) and so on. A fundamen-
tal part of the challenge now faced in the management
of older adults with multiple, interacting medical and
social problems is the need not just to adapt routines of
care, including clinical practice guidelines developed for
single illnesses, but to change a way of thinking which
views single system illness as normative.
Development of the concept of frailty
Frailty is widely understood to represent variable vulner-
ability to adverse health outcomes of people of the same
chronological age. In clinical medicine, it has its origins
in aiming to differentiate health care needs of older
adults, so as to show that “the elderly” are not homoge-
nous. In this sense of understanding differential vulner-
ability, the clinical term frailty shares an important
element with the statistical definition of frailty. In the
statistical literature, frailty quantifies the variability to
adverse outcomes (typically death) as a random effect
that differs between people but is constant for any indi-
vidual. Credit for primacy is given to Vaupel and collea-
gues for using the term frailty in this way in 1979 [8].
As is typical in science, the idea built on related con-
structs, such as Beard’s “longevity factor”, which came
from actuarial literature of some decades prior to that
[9]. As Beard conceived of it, the longevity factor char-
acterized individuals throughout their life course. A low
longevity factor value meant that people aged slowly; in
actuarial terms; this was meant that their chance of
dying increased more slowly than it did in people with a
high longevity factor value. Used in this way, although
the risk of death increased with age, it was constant for
a particular individual. By contrast, in the clinical
literature, frailty is considered to be different from this
in two ways. First, it is seen to be an attribute which
can change for given individuals, both increasing and
decreasing. Second, we use clinical data, not actuarial
data, and consider more outcomes than mortality. In
normal clinical use, frailty reflects the variable vulner-
ability to adverse health outcomes of people of the same
chronological age.
It is worth recalling that in the 1980s the idea of refin-
ing the profiles of various fitness and frailty states was a
common focus in academic geriatric medicine [10]. As
the discipline came of age at the same time as controlled
clinical trials were maturing, geriatricians sought to
define which older people were best suited to clinical
trials of specialized geriatric interventions. Then, as now,
the hallmark of the specialized geriatric intervention is
comprehensive geriatric assessment (CGA). A CGA is
the process by which systematic account is taken of the
multiple, interacting medical and social needs of older
adults, of how illness impacts on function, of how func-
tional dependence affects caregivers, and of how each of
these factors impact on the outcomes of health care. It is
worth recalling too that CGA has two parts: both the
identification of all these factors, and their management.
The CGA process is not simply the enumeration of pro-
blems, but is also a management plan to address them.
The particular concern in the era of controlled clinical
trials of CGA was that this time-consuming approach
should be targeted to those patients who were most likely
to benefit. Today, that geriatric medicine should target
frail older adults is a formula widely accepted [11-14],
but this view did not arise spontaneously, and even now,
to the extent that it might be seen to focus too much on
the outcomes and frailty and, thereby, unintentionally
undermine the concerns of preventing frailty, it is not
entirely without controversy.
Even so, if we begin by claiming that geriatric medi-
cine should focus on older adults who are frail, we must
then ask: “Who are the frail?” We must also recognize
that this focus on the frail by geriatricians cannot be a
proprietary claim; there are far too many frail older
adults and far too few geriatricians. Given that frailty is
increasingly understood as a common stage of the life
course [15], then it is obvious that it will fall to family
medicine and other primary care physicians to provide
the bulk of this care. With the importance of family
caregivers in the lives of people, who are dependent or
at risk for dependence, this review is directed towards
family physicians.
Frailty and its recognition in clinical practice
Frailty phenotype
Although the operational definition of frailty is widely
recognized as being as yet unsettled [16-20], in general,
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the frailty phenotype [21], in which in any individual
frailty can be recognized by the presence of at least
three of five particular deficits, specified as: measured
slow walking speed, measured impaired grip strength,
self-reports of declining activity levels, exhaustion and
unintended weight loss (this last can also be measured if
longitudinal data are available). People with three or
more of these deficits are said to be frail and those with
n o n ea r es a i dt ob er o b u s t .T h et e r m“pre-frail” is used
when only one or two of these deficits is present. The
originators of this consensus operational definition were
motivated in large measure by the need to identify a
group of people who would conform to the essence of
the definition of frailty (that is, who would demonstrate
an increased risk of adverse health outcomes) but who
would be both clinically recognizable and not otherwise
definable as being disabled (on which other operational
definition then extant rested [22] or as having multiple
co-morbid illnesses.)
The frailty index and its variants
Another approach to measuring frailty is to employ a
frailty index, which is a count of health deficits. A health
deficit can be any clinical symptom, sign, disease, dis-
ability, or laboratory, imaging or electrodiagnostic
abnormality. The rationale for counting deficits is
straight forward: the more things which an individual
has wrong with them, that is, the more deficits which
they accumulate, the greater their risk of an adverse
health outcome. In this sense, and recalling that the idea
of frailty is meant to better grade the risk of adverse
health outcomes amongst people of the same age, the
more deficits that someone has, the frailer they are.
There are notably few restrictions on what can be
counted as a health deficit, even though in different stu-
dies, which used only self-report, or mostly clinical data
or some combination of self-report, observer assessed
and test data [23], similar estimates of prevalence and
risk have been demonstrated. Usually, at least 30 items
are included in a frailty index, making it useful for sec-
ondary analyses of existing databases, including electro-
nic medical records [24].
To develop a frailty index from existing clinical
records requires assessing which variables might be con-
sidered as health deficits. Some guidelines, for which
items should be included, are best followed [25]. In gen-
eral, however, to be included, a health deficit should be
acquired, age-associated and associated with an adverse
outcome. Recent commentators are right to point out
that the number of deficits included in a frailty index,
(usually 30 or more), is as important as the nature of
any one of them [26]. For example, hypertension meets
all these criteria. If green eye colour were somehow
found to be associated with poor health, it would not be
included, because it is neither acquired nor age asso-
ciated. Another criterion is that the deficit not saturate
too early, that is, that it not be present in all or most
people (a reasonable criterion for saturation appears to
be about 80%, that is, any deficit present in more than
80% of people simply adds a number to both the
numerator and the denominator and, thereby, does not
help grade risk). Often the saturation rule is context
dependent. For example, in developing a frailty index to
track health risk in a group of people who all live in an
assisted living facility, there is little point in counting
dependence in Instrumental Activities of Daily Living
(IADLs), because that is a criterion for admission and so
everyone in this group would have it. By contrast, if the
intent was to develop a frailty index to stratify risk in
people who present to an acute care hospital, then
knowing IADL dependence would be clearly important,
as those with such dependence would be at higher risk
than those who were IADL independent [27].
Although the idea of counting deficits is simple, it
gives rise to results which are neither trivial nor obvious.
For example, in several studies, deficits consistently
accumulated exponentially with age, at an average rela-
tive rate of about three percent per year on a log scale.
This has held both in countries in the West [24], and in
China, even though the mortality associated with any
degree of frailty is higher in the latter than in the former
[28-30]. When considering how to adapt a frailty index
to work in a primary care practice, it is worth noting
that this consistency of result was obtained across many
different constructions of the frailty index. Briefly,
reflecting availability of items, different numbers of vari-
ables (from 20 to 130) and different variables themselves
were used in the different datasets. What is more, not
every dataset had equivalent items; the health variables
contained in each dataset notably varied in how many
functional disabilities, diagnoses and medications they
recorded [24]. Even so, in each dataset, increasing values
of the frailty index were highly associated with an
increased risk of death. When both are combined in a
multivariable model, in each case, the frailty index has
always better predicted mortality than has age. This
approach to counting deficits as a means of distinguish-
ing risk amongst older adults has been independently
confirmed in several studies [31-36].
In general, at any given age, women on average have
more deficits than do men. Even so, although their risk
increases with increasing values of the frailty index, for
any given frailty index value, the risk of adverse out-
comes is lower for women than for men [24]. In this
sense, women tolerate their deficits better than men do.
The biological basis for this better tolerance of deficits
by women has yet to be established, but the finding is
robust, and implies a system effect. Several explanations
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such that the price of more optimal physiological func-
tioning during youth is a lower threshold for system fail-
ure in old age [37].
Several variants of the frailty index exist. Typically,
they have been shortened by employing statistical tech-
niques (such as factor analysis) to reduce the number of
variables which are considered, and often weigh some
more than others to reflect their importance in predic-
tion [38-40]. In our experience, while a weighted frailty
index will offer better prediction retrospectively, if it is
tested in the same cohort in which it was derived, it
typically fails to generalize with these weights to other
samples [41,42]. For this reason, we tend to use index
measures with more variables and to not weight them.
In general, reproducibility of confidence limits is also
lower when fewer variables are considered [43], and it is
less easy to demonstrate grades of frailty, or to use mod-
eling techniques, which give insight into mechanisms
[24]. For these reasons, we tend to favour a frailty index
with multiple items. Even though it requires that more
information is considered, this is not inappropriate
when trying to assess what is wrong with patients who
have complex illnesses. Other, shorter frailty indices also
exist, such as the Study of Osteoporotic Fractures (SOF)
index developed and cross validated by Ensrud and col-
leagues [40,44]. It measures three items (weight loss,
inability to rise from a chair, and poor energy). In gen-
eral, very short indices are less able to be used for evalu-
ating complexity mathematically; also, they do not
ensure that relevant data (such as which illnesses a per-
son has, how they are treated, how they function,
whether they are safe in transfers - a constellation some-
times referred to as multidimensional impairment [45])
are collected. Where other processes are in place to
ensure that such information is incorporated into the
types of decisions for which a frailty measure might be
useful (for example, suitability for invasive or toxic pro-
cedures, need to hospitalize or institutionalize) then this
may be less a concern. One caveat when using abbre-
viated or simplified frailty screens is that people who
cannot perform performance measures should be seen
as especially at risk, and not as having “missing data”,
which is a common practice in epidemiological studies,
and can also be the case where protocols require adher-
ence to specific measures [46].
There are notable contrasts between the frailty pheno-
type [21] and the frailty index [24] approaches. Whereas
the frailty phenotype highly specifies which items should
be included in defining frailty, the frailty index approach
hardly specifies which items to include. However, the
frailty phenotype and index approaches also have much
in common. It is interesting to note that the five items
used in the phenotype definition can be combined in an
index (from 0 to 5). Although frailty is less commonly
graded by this approach, a dose response can be demon-
strated. A dose response has also been shown for the
three-item SOF index, based on phenotype items [40].
Even so, using just a few items is insensitive to early
stages of risk, and typically shows ceiling effects, in con-
trast to the submaximal limit which has been demon-
s t r a t e db yt h ef r a i l t yi n d e xmeasures that consist of 20
or more deficits [24]. In many situations, however,
doing even a few things might well be better than leav-
ing such items entirely unassessed. Although the three-
item SOF frailty index has been validated against the
five phenotypic items, clinical trials of abbreviated ver-
sus more comprehensive assessments would be helpful.
Does recognizing frailty improve clinical care?
Identifying frailty is the first step, but, as above, ulti-
mately the question that must be addressed is whether
recognizing frailty in primary care aids in the manage-
ment of people who are frail. It is widely accepted that
it is worth knowing about frailty as a means of improv-
ing care, although trials of frailty recognition versus
operating without the construct are lacking [18,47-51].
Frailty has been shown to be an independent marker for
worse outcomes following surgery, including postopera-
tive complications, mortality, length of stay and dis-
charge to care facilities [52-54]. As such, frailty has been
proposed as an additional component of pre-operative
risk classification and as a guide in informed decision
making for patients and families. Afilalo and colleagues
reviewed studies of frailty and cardiovascular disease
[55]. They identified that frailty confers an increased
mortality risk. They too propose that frailty could be
used to better define prognosis in frail patients with car-
diovascular disease. Singh and colleagues explicitly call
for early identification of frailty amongst patients with
cardiac disease to help tailor decision making, optimiza-
tion of other comorbidities and frame discussions about
prognosis and goals of care with patients and their
families [56]. Frailty has also been identified as an inde-
pendent marker for worse outcomes in patients dis-
charged from the emergency department [57]. Frailty
conferred an increased risk of death, hospitalization, and
admission to a long term care facility in the 30 days
after discharge. Extrapolating from this finding, frailty
could again be a key feature, if identified in the emer-
gency department setting, which might frame target
interventions and medical decision making. Robinson
and colleagues looked specifically at the healthcare cost
associated with surgery and the relationship to a
patient’s frailty. They found a clear relationship between
increased frailty and increased costs, not just at the time
of hospitalization for surgery, but at six months post
discharge [58]. Pulignano and colleagues identified that
moderately frail patients with heart failure benefited
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comes and improved healthcare costs [59]. Not only
does identifying frailty alter health outcomes, but it has
been shown that identifying frailty in primary care
allows for targeted interventions that reduce cost [60].
In the family medicine setting many medical deci-
sions revolve around preventive health manoeuvres,
such as screening tests or investigations. Identifying
frailty would allow for these discussions to be more
appropriately targeted to patients who might live to
see benefit from screening tests [61]. Strict definitions
of life expectancy often do not incorporate the
increased risk of mortality conferred by frailty, thus
making conversations about screening less applicable.
Braithwaite et al. present an updated framework that
incorporates frailty that can be used in clinical practice
to inform decisions around screening tests [61].
Although it still requires further development, their
model does point towards the benefit of incorporating
frailty into clinical decision making for frail patients.
Ultimately clinicians may be left with a roster of
screening tests that may confer benefit to their frail
older patients, and a more defined list of what is unli-
kely to be of benefit or even likely to cause harm. The
benefits of informed decision making that arise from
identifying frail patients are not only limited to preven-
tive health discussions. Including frailty in the
informed decision making for any medical intervention
has the potential to provide important information for
both clinician and patient and will allow more rational
and informed decisions [49]. Frailty provides a frame-
work for discussion about goals of care, including end
of life care goals. It may encourage proactive planning
on the part of the physician and the patient and their
family due to the sense of imminent morbidity and
ultimately mortality that accompanies frailty [62].
On this background, it seems reasonable to suggest
that identifying frailty is helpful in clinical decision mak-
ing, even if at the present we lack trials to show that
this changes outcomes [63]. Identifying frailty flags
increased risks for complications and mortality with
invasive interventions, thus empowering the physician to
have appropriate conversations about potential risks and
benefits with the patient and family. It allows primary
care physicians to make informed recommendations and
decisions around preventive and screening interventions,
and, thereby, has the potential to decrease unnecessary
or harmful medical testing. It provides a framework for
conversations around end of life care and goals of care.
It also provides a language and framework that primary
care physicians can use to describe challenging complex
patients who present in variable clinical states, but who
are all in the common stage known as frailty. Unfortu-
nately, integrating the identification of frailty and use of
frailty as a diagnostic category has been minimally
developed in family medicine.
Concept of frailty in primary care
A review of the literature reveals that frailty in primary
care is a topic in its infancy. Pub Med was systematically
searched for articles with key words “primary care” or
“family medicine” and “frailty”. Search results were lim-
ited to the English language, adults over age 65, and
articles published since 1990. With these requirements,
as of 4 October 2011, 45 papers fit the criteria. The
abstracts of the articles returned on the search were
reviewed for relevance to family medicine or primary
care. Specifically, articles were chosen if the study was
in a primary care setting, the interventions were per-
formed by a primary care provider and the patient
population was a broad frail patient group, rather than a
specific subtype of frail patient with targeted diseases.
A n yo ft h ea r t i c l e sw i t hh i g hr e l e v a n c ew e r et h e n
reviewed and any key references that were relevant to
family medicine or primary care and frailty were exam-
ined. While De Lepeleire’s “Frailty: an emerging concept
for general practice” directly addresses the potential for
frailty as a concept to be utilized in primary care, for
the most part frailty and its application as a concept in
family medicine are minimally developed [51].
Many of the studies that fall under “primary care” and
“frailty” utilize or test screening tools that are not
directly applicable to a family physician’s office or that
are still in the preliminary phases of development. Many
are in the phase of identifying which factors could be
used to identify frailty, but do not actually test the appli-
cation in primary care [64-66]. Other articles extrapolate
from research conditions and propose the feasibility in a
family medicine setting. A recent report using the
Edmonton Frail Scale [67] is one such example [68].
Many studies use various methods to screen for frailty
including questionnaires and established frailty criteria,
as a way to identify groups of patients for further inter-
ventions [66,69]. The applicability of these screening
techniques in a family physician’s office largely has not
been studied except by Cavazzini and colleagues who
tested the hypothesis that primary care physicians can
easily screen for poor lower extremity function in the
daily routine of their clinics [70]. They concluded from
their small sample of 23 physicians that this was feasi-
ble. This study was expanded on in the Frasi trial in
which 39 primary care physicians used the Short Physi-
cal Performance Battery, previously tested by Cavazzini,
to identify frail older patients who were in for a routine
visit to their primary care doctor [71]. The SHARE Fra-
ily Index is another tool which is meant to facilitate
screening for frailty in primary care [72]. A web-based
calculator was developed that would determine a frailty
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lar measurements pertaining to their patient. Like many
others this tool was developed in the research realm and
not tested in a primary care clinic setting for acceptabil-
ity and ease of use. Other groups have tried to use alter-
nate markers for identifying frail patients. Maly et al.
have published a preliminary report that tried to identify
what screening questions could be used to better iden-
tify which frail older people in the outpatient setting
would benefit from further Comprehensive Geriatric
Assessment [73]. They hypothesized that abnormal
results on validated screening measures for geriatric syn-
dromes might serve as a proxy for frailty. While they
recognize that further work is needed to clarify these
questions, if screening questions were proven to be sur-
rogate markers they might be feasibly incorporated in
primary care settings.
No clear winner emerges from the slim field of stu-
dies that test the accessibility and applicability of
screening tests for frailty in family medicine [74]. Cer-
tainly, as many of the authors have stated, work in the
field of frailty in primary care, and more specifically
what tools to use to allow family physicians to quickly
and reliably identify their frail older patients, is just
beginning. More studies are needed to explicitly look at
the feasibility of screening tools in the family medicine
setting and even more broadly speaking, how to encou-
rage the adoption of the concept of frailty by family
physicians and then, how to allow it to inform manage-
ment. Even so, it is important to note that a lot of
research, touching essentially the same questions in pri-
mary care [75-79], might be neglected, only to be redis-
c o v e r e d-i fn o to u t r i g h tl o s t-i n“new” research that
screens for frailty. If frailty tools are harder to imple-
ment in primary care, then there will be no net benefit.
On the other hand, to the extent that current instru-
ments might duplicate what is essential to know in eval-
uating fitness and frailty, and that the range might
adequately be covered by a single comprehensive assess-
ment, this may be less a concern than might be ima-
gined. Clearly, studies comparing multi-part,
hierarchical staged tools would be useful. In general, the
concept of high order functions, which integrate across
many bodily systems, such as mobility, balance, func-
tion, attention, self-efficacy and social interaction (these
are sometimes referred to as “state variables” [24])
could serve as useful means to track the overall state of
health, broadly construed.
Family Medicine as specialty has advantage to
understanding frailty
Family physicians are already well poised to incorporate
the concept of frailty into the care of their older
patients. The philosophy of family medicine encourages
a patient centered approach that takes into account
individual goals of care, beliefs, preferences, social con-
text and patients’ experiences of illness. As such, the
concept of frailty would allow for an expansion of these
core values and skills when caring for the frail older
people. It would allow family physicians to use a frame-
work they are already comfortable using and apply it to
a patient population that often feels overwhelming. By
naming the complexity, that is, naming the vague feeling
of concern, futility and challenge that often accompanies
caring for the frail older person in a busy family physi-
cian’s office, the physician can begin making clinical
decisions and treatment recommendations in the con-
text of frailty and its accompanying risks. It could also
allow for more targeted interventions and avoidance of
inappropriate ones. Moreover, adopting the concept of
frailty in primary care has the potential to allow earlier
identification of patients who are at risk and who are
moving in and out of the frailty continuum. Again
family medicine is well positioned to act on identifying
those at risk for frailty [60]; this is an area in which
further research is needed, but where little is likely to be
lost by at least recognizing the complexity of their
needs. Preventive medicine is a core component of pri-
mary care and family medicine, and if frailty was under-
stood to be amendable to preventive measures it could
be incorporated into the existing preventive medicine
framework. This equally applies to secondary and ter-
tiary prevention, especially in relation to the increased
rate of adverse outcomes which arise when complex
interventions are undertaken in people whose functional
status and frailty go unrecognized [52,80]. As much of
this information is readily known by primary care physi-
cians, but typically does not make it way into preopera-
tive assessments, there would appear to be a very useful,
if often under-exploited role, for the primary care physi-
cian in the assessment of pre-operative risk, especially in
patients undergoing elective procedures, including che-
motherapy [81].
Family physicians are well poised to identify frail
patients in their practice. Doing so will allow focused
interventions and recommendations about medical man-
agement. There is good evidence that identifying frail
patients will improve clinical outcomes and there is
increasing evidence that it is cost effective. The final
barrier of finding a method that is feasible for use in
primary care, but comprehensive enough to allow non-
arbitrary decisions to be made and justified requires
further study. For now, addressing frailty in some way is
clearly preferable to not addressing it at all. The disci-
p l i n eo fu s i n gt h er e s u l to ft he frailty assessment to
develop pragmatic care plans would seem to favour
basing a frailty assessment on enough information
needed to make care better.
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This review has drawn to attention how the complexity
of frailty is a challenge to traditional health care deliv-
ery, which often is based on a single diagnosis. In this
regard, primary care medicine is better placed than
many other specialties, in having a greater focus on the
patient. This has also drawn to attention the critical role
for primary care physicians in the management of older
adults who are frail. This is not making a virtue of
necessity (there being too few geriatricians) but in
recognition that for many people an extended period of
frailty will be an important part of their life course,
which needs to be managed appropriately, and that the
thoughtful focus on the person and not just their ill-
nesses is a hallmark of proper primary care. Further
study needs to occur to develop and test tools for frailty
screening in the primary care setting. Once these tools
are developed, frailty as a diagnostic category with the
accompanying risks and poor prognosis can be incorpo-
rated into many clinical decisions and discussions. Ulti-
mately the goal of facilitating the identification of frail
patients in the primary care setting is to improve the
quality of sensible patient centered care provided to frail
older patients.
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